![]() |
市場調查報告書
商品編碼
1702200
2025 年至 2033 年壓力襪市場報告,按產品類型(及膝襪、大腿襪)、人口統計(男性、女性)、配銷通路(線下、線上)和地區分類Compression Stockings Market Report by Product Type (Knee High, Thigh High), Demography (Men, Women), Distribution Channel (Offline, Online), and Region 2025-2033 |
2024 年全球壓力襪市場規模達 17 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 25 億美元,2025-2033 年期間的成長率 (CAGR) 為 4.23%。市場的主要驅動力是靜脈疾病盛行率的不斷上升、人們對健康意識的不斷增強以及人口老化的不斷增加。此外,人們對壓力療法益處的認知不斷提高,進一步鼓勵人們採用這些襪子,從而促進市場成長。
壓力襪對腳踝和小腿施加輕柔的壓力,以改善血液流動,抑制血栓形成並減輕疼痛。因此,它們有助於預防水腫、淋巴水腫、靜脈炎、蜘蛛靜脈和靜脈曲張以及深部靜脈栓塞 (DVT)。它們還有助於改善懷孕期間與靜脈功能不全相關的下肢症狀。除此之外,它們還可以作為直立性低血壓(OH)患者的非藥物治療選擇。一些常用的壓力襪包括漸進式壓力襪(GCS)、抗栓塞襪和非醫用支持襪。
慢性靜脈疾病 (CVD) 普遍存在,診斷不足,並可能發展為慢性靜脈功能不全 (CVI) 和靜脈性腿部潰瘍 (VLU),需要大量治療和住院。再加上久坐不動的生活方式導致肥胖症的日益流行,這是推動市場成長的關鍵因素之一。除此之外,使用壓力襪的壓迫療法有助於治療下肢靜脈潰瘍,因為它可以促進潰瘍癒合、減輕疼痛並防止復發。它還有助於縮小靜脈,恢復瓣膜功能,最大限度地降低動態靜脈壓力,並減少靜脈回流(VR)。此外,它有助於減少發炎細胞因子和降低毛細血管液體滲漏,從而減輕肢體水腫。此外,領先的參與者越來越注重積極的促銷活動,向跑步者、鐵人三項運動員和其他耐力運動員宣傳壓力襪。這些長襪可以增強體力活動期間的血液循環,提高運動表現,並促進快速恢復。這與蓬勃發展的體育產業一起,提高了整體銷售額和獲利能力。此外,預計全球老年人口的增加將推動市場成長。
The global compression stockings market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.23% during 2025-2033. The market is majorly driven by the growing prevalence of venous disorders, rising awareness about health and wellness, and an increasing aging population. Additionally, steadily rising awareness regarding the benefits of compression therapy is further encouraging adoption of these stocking, thereby contributing to the market growth.
Compression stockings apply gentle pressure over the ankles and calves to improve blood flow, inhibit the formation of blood clots, and reduce pain. As a result, they help prevent edema, lymphedema, phlebitis, spider and varicose veins, and deep vein thrombosis (DVT). They also aid in improving lower extremity symptoms associated with venous insufficiency during pregnancy. Besides this, they can be used as a non-pharmacological treatment option for individuals with orthostatic hypotension (OH). Some of the commonly used compression stockings include graduated compression stockings (GCS), anti-embolism stockings, and non-medical support hosiery.
Chronic venous disease (CVD) is widespread, underdiagnosed, and can progress to chronic venous insufficiency (CVI) and venous leg ulcers (VLU), which require extensive treatment and hospitalization. This, coupled with the rising prevalence of obesity on account of sedentary lifestyles, represents one of the key factors bolstering the growth of the market. Besides this, compression therapy using compression stockings assists in the treatment of VLU as it results in ulcer healing, reduction of pain, and prevention of recurrence. It also helps narrow veins, restore valve competence, minimize ambulatory venous pressure, and reduce venous reflux (VR). In addition, it aids in decreasing inflammatory cytokines and lowering capillary fluid leakage, thereby alleviating limb edema. Moreover, leading players are increasingly focusing on aggressive promotional activities for advertising compression stockings to runners, triathletes, and other endurance athletes. These stockings enhance blood circulation during physical activity, boost athletic performance, and enable rapid recovery. This, along with the burgeoning sports industry, is augmenting the overall sales and profitability. Furthermore, the increasing geriatric population around the world is projected to fuel the market growth.
The competitive landscape of the industry has also been examined along with the profiles of the key players being 2XU Pty Ltd., Bauerfeind AG, Belsana, Creswell Sock Mills, DJO LLC (Enovis Corporation), Gloria Med Spa, Manifattura Cizeta s.r.l., medi GmbH & Co. KG, Sigvaris AG (Sigvaris Management AG), Spanx Inc., Thuasne and Triumph Home Health Supplies.